The FDA-approved smoking cessation pill, varenicline, offers new hope for those struggling with nicotine addiction, particularly among teenagers and young adults seeking to quit vaping.Recent clinical trials have demonstrated that participants using varenicline experienced over three times the success rate in overcoming their vaping habits compared to those on placebo treatments.